Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179(2):312–339. https://doi.org/10.1016/j.cell.2019.09.001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, Iqbal K, Jessen F, Johansson G, Jonsson L, Kivipelto M, Knapp M, Mangialasche F, Melis R, Nordberg A, Rikkert MO, Qiu C, Sakmar TP, Scheltens P, Schneider LS, Sperling R, Tjernberg LO, Waldemar G, Wimo A, Zetterberg H (2016) Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol 15(5):455–532. https://doi.org/10.1016/S1474-4422(16)00062-4

Article  PubMed  Google Scholar 

Derouesne C (2008) [Alzheimer and Alzheimer’s disease: the present enlighted by the past. An historical approach]. Psychol Neuropsychiatr Vieil 6 (2):115–128. https://doi.org/10.1684/pnv.2008.0122

Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1(1):a006189. https://doi.org/10.1101/cshperspect.a006189

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cummings J (2023) Anti-amyloid monoclonal antibodies are transformative treatments that redefine Alzheimer’s disease therapeutics. Drugs 83(7):569–576. https://doi.org/10.1007/s40265-023-01858-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown GC (2019) The endotoxin hypothesis of neurodegeneration. J Neuroinflammation 16(1):180. https://doi.org/10.1186/s12974-019-1564-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bahador M, Cross AS (2007) From therapy to experimental model: a hundred years of endotoxin administration to human subjects. J Endotoxin Res 13(5):251–279. https://doi.org/10.1177/0968051907085986

Article  CAS  PubMed  Google Scholar 

Sandiego CM, Gallezot JD, Pittman B, Nabulsi N, Lim K, Lin SF, Matuskey D, Lee JY, O’Connor KC, Huang Y, Carson RE, Hannestad J, Cosgrove KP (2015) Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci U S A 112(40):12468–12473. https://doi.org/10.1073/pnas.1511003112

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang R, Miller RG, Gascon R, Champion S, Katz J, Lancero M, Narvaez A, Honrada R, Ruvalcaba D, McGrath MS (2009) Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol 206(1–2):121–124. https://doi.org/10.1016/j.jneuroim.2008.09.017

Article  CAS  PubMed  Google Scholar 

Andreadou EG, Katsipis G, Tsolaki M, Pantazaki AA (2021) Involvement and relationship of bacterial lipopolysaccharides and cyclooxygenases levels in Alzheimer’s disease and mild cognitive impairment patients. J Neuroimmunol 357:577561. https://doi.org/10.1016/j.jneuroim.2021.577561

Article  CAS  PubMed  Google Scholar 

Zhan X, Stamova B, Sharp FR (2018) Lipopolysaccharide associates with amyloid plaques, neurons and oligodendrocytes in Alzheimer’s disease brain: a review. Front Aging Neurosci 10:42. https://doi.org/10.3389/fnagi.2018.00042

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim HS, Kim S, Shin SJ, Park YH, Nam Y, Kim CW, Lee KW, Kim SM, Jung ID, Yang HD, Park YM, Moon M (2021) Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications. Transl Neurodegener 10(1):49. https://doi.org/10.1186/s40035-021-00273-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown GC, Heneka MT (2024) The endotoxin hypothesis of Alzheimer’s disease. Mol Neurodegener 19(1):30. https://doi.org/10.1186/s13024-024-00722-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JW, Lee YK, Yuk DY, Choi DY, Ban SB, Oh KW, Hong JT (2008) Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation 5:37. https://doi.org/10.1186/1742-2094-5-37

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Z, Ni J, Liu Y, Teeling JL, Takayama F, Collcutt A, Ibbett P, Nakanishi H (2017) Cathepsin B plays a critical role in inducing Alzheimer’s disease-like phenotypes following chronic systemic exposure to lipopolysaccharide from Porphyromonas gingivalis in mice. Brain Behav Immun 65:350–361. https://doi.org/10.1016/j.bbi.2017.06.002

Article  CAS  PubMed  Google Scholar 

Bahar B, Singhrao SK (2021) An evaluation of the molecular mode of action of trans-resveratrol in the Porphyromonas gingivalis lipopolysaccharide challenged neuronal cell model. Mol Biol Rep 48(1):147–156. https://doi.org/10.1007/s11033-020-06024-y

Article  CAS  PubMed  Google Scholar 

Zhang Y, Feng S, Nie K, Li Y, Gao Y, Gan R, Wang L, Li B, Sun X, Wang L, Zhang Y (2018) TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson’s disease. Biochem Biophys Res Commun 499(4):797–802. https://doi.org/10.1016/j.bbrc.2018.03.226

Article  CAS  PubMed  Google Scholar 

Mizobuchi H, Soma GI (2021) Low-dose lipopolysaccharide as an immune regulator for homeostasis maintenance in the central nervous system through transformation to neuroprotective microglia. Neural Regen Res 16(10):1928–1934. https://doi.org/10.4103/1673-5374.308067

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R (2006) Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J Neurosci 26(40):10129–10140. https://doi.org/10.1523/jneurosci.1202-06.2006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paxinos G, Franklin KBJ (2012) Paxinos and Franklin’s the mouse brain in stereotaxic coordinates. Elsevier Science

Google Scholar 

Shin SJ, Nam Y, Park YH, Kim MJ, Lee E, Jeon SG, Bae BS, Seo J, Shim SL, Kim JS, Han CK, Kim S, Lee YY, Moon M (2021) Therapeutic effects of non-saponin fraction with rich polysaccharide from Korean red ginseng on aging and Alzheimer’s disease. Free Radic Biol Med 164:233–248. https://doi.org/10.1016/j.freeradbiomed.2020.12.454

Article  CAS  PubMed  Google Scholar 

Kim S, Nam Y, Kim C, Lee H, Hong S, Kim HS, Shin SJ, Park YH, Mai HN, Oh SM, Kim KS, Yoo DH, Chung WK, Chung H, Moon M (2020) Neuroprotective and anti-inflammatory effects of low-moderate dose ionizing radiation in models of Alzheimer’s disease. Int J Mol Sci 21 (10). https://doi.org/10.3390/ijms21103678

Haque MM, Kim D, Yu YH, Lim S, Kim DJ, Chang YT, Ha HH, Kim YK (2014) Inhibition of tau aggregation by a rosamine derivative that blocks tau intermolecular disulfide cross-linking. Amyloid 21(3):185–190. https://doi.org/10.3109/13506129.2014.929103

Article  CAS  PubMed  Google Scholar 

Lim S, Haque MM, Kim D, Kim DJ, Kim YK (2014) Cell-based models to investigate tau aggregation. Comput Struct Biotechnol J 12(20–21):7–13. https://doi.org/10.1016/j.csbj.2014.09.011

Article  PubMed  PubMed Central  Google Scholar 

Arad E, Green H, Jelinek R, Rapaport H (2020) Revisiting thioflavin T (ThT) fluorescence as a marker of protein fibrillation - the prominent role of electrostatic interactions. J Colloid Interface Sci 573:87–95. https://doi.org/10.1016/j.jcis.2020.03.075

Article  CAS  PubMed  Google Scholar 

Chen C, Ma X, Wei J, Shakir N, Zhang JK, Zhang L, Nehme A, Cui Y, Ferguson D, Bai F, Qiu S (2022) Early impairment of cortical circuit plasticity and connectivity in the 5XFAD Alzheimer’s disease mouse model. Transl Psychiatry 12(1):371. https://doi.org/10.1038/s41398-022-02132-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eimer WA, Vassar R (2013) Neuron loss in the 5XFAD mouse model of Alzheimer’s disease correlates with intraneuronal Abeta42 accumulation and caspase-3 activation. Mol Neurodegener 8:2. https://doi.org/10.1186/1750-1326-8-2

Article  CAS